ATE174603T1 - Faktor iia inhibitoren - Google Patents

Faktor iia inhibitoren

Info

Publication number
ATE174603T1
ATE174603T1 AT92903870T AT92903870T ATE174603T1 AT E174603 T1 ATE174603 T1 AT E174603T1 AT 92903870 T AT92903870 T AT 92903870T AT 92903870 T AT92903870 T AT 92903870T AT E174603 T1 ATE174603 T1 AT E174603T1
Authority
AT
Austria
Prior art keywords
group
present
nle
nal
ile
Prior art date
Application number
AT92903870T
Other languages
English (en)
Inventor
Nispen Johannes Wilhelmus Van
Henricus Carl Joseph Ottenheym
Jacobus Albertus Maria Peters
Arie Visser
Willemientje Jetten
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of ATE174603T1 publication Critical patent/ATE174603T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/815Protease inhibitors from leeches, e.g. hirudin, eglin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02Linear peptides containing at least one abnormal peptide link
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT92903870T 1991-02-04 1992-02-04 Faktor iia inhibitoren ATE174603T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91200201 1991-02-04

Publications (1)

Publication Number Publication Date
ATE174603T1 true ATE174603T1 (de) 1999-01-15

Family

ID=8207509

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92903870T ATE174603T1 (de) 1991-02-04 1992-02-04 Faktor iia inhibitoren

Country Status (11)

Country Link
US (1) US5719128A (de)
EP (2) EP0570428B1 (de)
JP (1) JPH06505001A (de)
KR (1) KR930703348A (de)
AT (1) ATE174603T1 (de)
AU (1) AU656947B2 (de)
CA (1) CA2101331A1 (de)
DE (1) DE69227895D1 (de)
FI (1) FI933454A0 (de)
NO (1) NO932769L (de)
WO (1) WO1992013877A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5391705A (en) * 1991-03-15 1995-02-21 Merrell Dow Pharmaceuticals Inc. Polyfluorinated tripeptide thrombin inhibitors
CA2175078A1 (en) * 1993-12-09 1995-06-15 Eduard Felder Process for the production of combinatorial compound libraries
US6069232A (en) * 1995-10-02 2000-05-30 Hoechst Marion Roussel, Inc. Polyfluoroalkyl tryptophan tripeptide thrombin inhibitors
US5739354A (en) * 1996-03-26 1998-04-14 Hoechst Marion Roussel, Inc. Process for the preparation of N-methyl-D-phenylalanyl-N- 1- 3- (aminoiminomethyl)amino!propyl!-3,3-difluoro-2-oxohexyl!-L-prolinamide
WO2003022873A1 (de) * 2001-09-10 2003-03-20 Novel Science International Gmbh Organische verbindungen mit biologischer wirkung als thrombinhemmer und ihre verwendung
CN102225966B (zh) 2004-10-19 2012-12-26 隆萨股份公司 用于固相肽合成的方法
EP3322714B1 (de) * 2015-07-13 2020-09-30 Universiteit Gent Hydrogelerzeugende peptide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4318904A (en) * 1980-04-25 1982-03-09 Research Corporation Peptide affinity labels for thrombin and other trypsin-like proteases
GB8305985D0 (en) * 1983-03-04 1983-04-07 Szelke M Enzyme inhibition
IT251700Y1 (it) * 2000-01-21 2004-01-20 Lotto Sport Italia Spa Struttura di suola

Also Published As

Publication number Publication date
FI933454A (fi) 1993-08-03
DE69227895D1 (de) 1999-01-28
AU1193392A (en) 1992-09-07
NO932769D0 (no) 1993-08-03
EP0498508A1 (de) 1992-08-12
KR930703348A (ko) 1993-11-29
EP0570428A1 (de) 1993-11-24
EP0570428B1 (de) 1998-12-16
JPH06505001A (ja) 1994-06-09
NO932769L (no) 1993-08-03
WO1992013877A1 (en) 1992-08-20
FI933454A0 (fi) 1993-08-03
CA2101331A1 (en) 1992-08-05
US5719128A (en) 1998-02-17
AU656947B2 (en) 1995-02-23

Similar Documents

Publication Publication Date Title
HUP9901209A2 (hu) Opioid analóg peptid vegyületek, eljárás előállításukra és ezeket a vegyületeket tartalmazó gyógyszerkészítmények
HUP9901319A2 (hu) 9-Hidroxi-riszperidon zsírsavészterek vizes szuszpenziói, előállításuk és alkalmazásuk
IE820465L (en) Peptides
PE109698A1 (es) Aminoacidos modificados, medicamentos que contienen estos compuestos y procedimiento para su preparacion
ATE194846T1 (de) Zyklische antimikrobielle peptide und deren herstellung
LV12350A (lv) Heptapeptida oksitocina analogi
DE69227895D1 (de) FAKTOR IIa INHIBITOREN
KR910014395A (ko) 신규 화합물
ATE63750T1 (de) Peptid, dessen herstellung und benutzung.
KR900016238A (ko) 신규 화합물
ES2081817T3 (es) Polipeptido con secuencias principales repetidas que se fijan en la celula.
EP0206090A3 (de) Peptid-Renin-Inhibitoren
KR880011198A (ko) 사이클릭 펩타이드 및 이의 제조방법
ES2012720A6 (es) Procedimiento para la obtencion de sales de adicion de acido de taurina o glicina amidada.
KR850006941A (ko) 데스-프로린 바조프레신 길항제의 제조방법
ATE47880T1 (de) Vorlaeufer eines an dem c-ende amidierten peptids und dessen herstellung.
ATE6148T1 (de) Hexapeptide, deren herstellung, deren anwendung in arzneimitteln und sie enthaltende zusammensetzungen.
EP0361977A3 (de) Peptide mit T-Zellensuppressor-Wirksamkeit
ES536117A0 (es) Un procedimiento para preparar heptapeptidos y hexapeptidos ciclicos antagonistas de la vasopresina
DE3867039D1 (de) Vincristin enthaltendes produkt.
EP0307662A3 (de) Enkephalin-Analoge
IT1230733B (it) Analoghi della timopentina retro invertita a tutti i legami, il metodo per la loro sintesi ed il loro impiego per la preparazione di composizioni farmaceutiche.
ATE10934T1 (de) Peptid, verfahren zu dessen herstellung und dessen verwendung.
JPS6450896A (en) Contraction suppressing peptide
TH2217A (th) กรรมวิธีในการเตรียมเฮพทาเพบไทด์ที่มีฤทธิ์เป็นด่างและต่อต้านวาโซเพรสซิน

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties